Intech Investment Management LLC Lowers Stock Holdings in DaVita Inc. (NYSE:DVA)

Intech Investment Management LLC trimmed its stake in DaVita Inc. (NYSE:DVA) by 3.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 81,495 shares of the company’s stock after selling 3,060 shares during the period. Intech Investment Management LLC’s holdings in DaVita were worth $8,537,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently added to or reduced their stakes in DVA. Hanseatic Management Services Inc. purchased a new stake in DaVita in the 3rd quarter valued at about $36,000. Principal Securities Inc. purchased a new stake in DaVita in the 4th quarter valued at about $37,000. GAMMA Investing LLC bought a new stake in shares of DaVita in the 4th quarter valued at about $60,000. Quest Partners LLC bought a new position in shares of DaVita during the fourth quarter valued at approximately $74,000. Finally, Tacita Capital Inc bought a new position in shares of DaVita during the third quarter valued at approximately $118,000. 90.12% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at DaVita

In related news, CEO Javier Rodriguez sold 67,603 shares of the firm’s stock in a transaction on Monday, February 26th. The shares were sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the sale, the chief executive officer now owns 488,697 shares in the company, valued at $61,629,578.67. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, Director Barbara J. Desoer sold 5,030 shares of the firm’s stock in a transaction on Friday, May 10th. The shares were sold at an average price of $138.81, for a total transaction of $698,214.30. Following the sale, the director now owns 10,954 shares in the company, valued at $1,520,524.74. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Javier Rodriguez sold 67,603 shares of DaVita stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the completion of the sale, the chief executive officer now owns 488,697 shares in the company, valued at approximately $61,629,578.67. The disclosure for this sale can be found here. Company insiders own 2.00% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the stock. UBS Group increased their price objective on shares of DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, February 14th. Barclays increased their target price on shares of DaVita from $133.00 to $150.00 and gave the company an “equal weight” rating in a research report on Monday, May 6th. TheStreet raised shares of DaVita from a “c+” rating to a “b-” rating in a report on Wednesday, February 7th. Truist Financial raised their price target on shares of DaVita from $135.00 to $150.00 and gave the stock a “hold” rating in a report on Wednesday, May 15th. Finally, StockNews.com cut shares of DaVita from a “strong-buy” rating to a “buy” rating in a report on Monday, May 6th. Two equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, DaVita has a consensus rating of “Moderate Buy” and an average price target of $144.67.

DaVita Stock Performance

Shares of NYSE:DVA traded up $6.29 during midday trading on Friday, reaching $138.54. The company’s stock had a trading volume of 1,169,810 shares, compared to its average volume of 950,995. The firm has a market capitalization of $12.15 billion, a PE ratio of 15.74, a P/E/G ratio of 1.06 and a beta of 1.04. DaVita Inc. has a twelve month low of $71.51 and a twelve month high of $145.04. The stock has a fifty day moving average of $135.26 and a 200 day moving average of $119.00. The company has a quick ratio of 1.37, a current ratio of 1.43 and a debt-to-equity ratio of 7.95.

DaVita (NYSE:DVA) last released its quarterly earnings data on Thursday, May 2nd. The company reported $2.38 earnings per share for the quarter, topping analysts’ consensus estimates of $1.95 by $0.43. The firm had revenue of $3.07 billion for the quarter, compared to analyst estimates of $3.03 billion. DaVita had a net margin of 6.61% and a return on equity of 68.52%. The business’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.58 earnings per share. On average, equities analysts expect that DaVita Inc. will post 9.62 EPS for the current fiscal year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.